A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia | NCT01678924 | Trialant
TerminatedInterventionalPhase 2Updated Jan 7, 2020
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
ClinicalTrials.gov ID
NCT01678924
Lead Sponsor
AllerganINDUSTRY
Overall Status
Terminated
Study Type
Interventional
Phase
Phase 2
Enrollment
280Actual
Last Update Posted
Jan 7, 2020Actual
Start Date
Jan 2013
Primary Completion Date
May 2015Actual
Completion Date
Sep 2015Actual
Brief Summary
This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).
Neuralgia, Postherpetic
AGN-214868
AGN-214868 Placebo (Vehicle)
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Postherpetic neuralgia with pain present for at least 9 months
Exclusion Criteria:
Active herpes zoster skin rash
Anticipated treatment for postherpetic neuralgia during the first 3 months of the study, including oral and topical medications, acupuncture, spinal cord stimulation, transcutaneous nerve stimulation (TNS), or trigger point injection
Anticipated treatment with pain medication for the treatment of postherpetic neuralgia during the first 3 months of the study
Use of capsaicin treatment for postherpetic neuralgia within 6 months, or anticipated use during the first 3 months of the study
Use of botulinum toxin of any serotype for any reason within 6 months, or anticipated use during the study
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Double
No central contacts
There are no central contacts for this study.
Agave Clinical Research, LLC
Mesa, Arizona 85202, United States
Territory Neurology & Research Institute
Tucson, Arizona 85704, United States
Neuro-Pain Medical Center
Fresno, California 93710, United States
University of California, Irvine
Irvine, California 92697, United States
Loma Linda University
Loma Linda, California 92354, United States
Northern California Research Corp
Sacramento, California 95821, United States
Neurological Research Institute
Santa Monica, California 90404, United States
Alpine Clinical Research Center
Boulder, Colorado 80301, United States
The Mile High Research Center
Denver, Colorado 80218, United States
Riverside Clinical Research
Edgewater, Florida 32132, United States
Compass Research, LLC
Orlando, Florida 32806, United States
Drug Studies America
Marietta, Georgia 30060, United States
Injury Care Research, LLC
Boise, Idaho 83713, United States
Millennium Pain Center
Bloomington, Illinois 61701, United States
Beacon Clinical Research
Brockton, Massachusetts 02301, United States
Springfield Neurology Associates, LLC
Springfield, Massachusetts 01104, United States
Michigan Head Pain and Neurology Institute
Ann Arbor, Michigan 48104, United States
Quest Research Institute
Farmington Hills, Michigan 48334, United States
Center for Pharmaceutical Research
Kansas City, Missouri 64114, United States
Clinvest Headache Care Center
Springfield, Missouri 65807, United States
Albuquerque Neuroscience, Inc.
Albuquerque, New Mexico 87109, United States
The Medical Research Network, LLC
New York, New York 10128, United States
Island Neurological Associates, P.C.
Plainview, New York 11803-4491, United States
Wake Research Associates
Raleigh, North Carolina 27612, United States
Plains Medical Clinic
Fargo, North Dakota 58104, United States
COR Clinical Research, LLC
Oklahoma City, Oklahoma 73103, United States
Allegheny Pain Management
Altoona, Pennsylvania 16602, United States
Omega Medical Research
Warwick, Rhode Island 02886, United States
Clinical Trials of South Carolina, LLC
Charleston, South Carolina 29406, United States
PharmaCorp Clinical Trials, Inc
Charleston, South Carolina 29412, United States
Clinical Research of Charleston
Mt. Pleasant, South Carolina 29464, United States
Center for Clinical Studies
Webster, Texas 77598, United States
MultiCare Neuroscience Center of Washington
Tacoma, Washington 98405, United States
AKH Wien
Vienna, 1090, Austria
Wilhelminenspital der Stadt Wien
Vienna, 1160, Austria
SMZ-Ost Donauspital
Vienna, A-1220, Austria
Pro scientia med im MARE Klinikum
Kiel, Schleswig-Holstein 24119, Germany
Berlin Research Centre
Berlin, 12627, Germany
Regionales Schmerzzentrum DGS
Bielefeld, 33602, Germany
Bochum Research Centre
Bochum, 44787, Germany
Das Schmerzzentrum Celle
Celle, 29221, Germany
Ambulant study centre
Cologne, 50935, Germany
Leiter des Universitats Schmerz Centrums (USC)
Dresden, 01307, Germany
Neuro-Consil GmbH
Düsseldorf, D-40212, Germany
Frankfurt Research Centre
Frankfurt, 60596, Germany
Schmerz und Palliativzentrum Fulda
Fulda, 36039, Germany
Schmerz und Palliativ- Zentrum Goeppingen
Göppingen, 73033, Germany
Klinikum Hanau GmbH
Hanau, 63450, Germany
Neurologische Praxis Heidenheim
Heidenheim, 89518, Germany
Facharzt fur Neurologie
Hoppegarten, 15366, Germany
Schmerzklinik Kiel
Kiel, 24149, Germany
Medamed GmbH
Leipzig, 04109, Germany
Leipzig Research Centre
Leipzig, D-04103, Germany
Magdeburg Research Centre
Magdeburg, 39104, Germany
Regionales Schmerz- und Palliativ Zentrum DGS Mainz